Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Thomas J. Gaudette"'
Autor:
Anthony J. Devaney, Thomas J. Gaudette, Daniel O. Hogenboom, Scott C. Lindberg, Charles A. DiMarzio
Publikováno v:
Optics letters. 23(10)
Quadrature detection techniques have been applied to images obtained from a Mach-Zehnder interferometer with differently polarized beams to yield the real and the imaginary parts of the diffracted fields simultaneously. This approach eliminates the n
Autor:
Abigail A. Baird, Natalie Hershlag, Thomas J. Gaudette, Kathryn A. Walz, Jerome Kagan, David A. Boas
Publikováno v:
NeuroImage. 16(4)
The ability to create and hold a mental schema of an object is one of the milestones in cognitive development. Developmental scientists have named the behavioral manifestation of this competence object permanence. Convergent evidence indicates that f
Autor:
Richard J. Gaudette, David A. Boas, Thomas J. Gaudette, Eric L. Miller, Charles A. DiMarzio, Misha E. Kilmer, Dana H. Brooks
Publikováno v:
Physics in medicine and biology. 45(4)
We compare, through simulations, the performance of four linear algorithms for diffuse optical tomographic reconstruction of the three-dimensional distribution of absorption coefficient within a highly scattering medium using the diffuse photon densi
Publikováno v:
SPIE Proceedings.
The interaction of ultrasound with diffusive optical waves holds the promise of improved resolution and depth of penetration for non-ionizing, non-invasive medical imaging. Light offers the ability to make spectroscopic measurements, which can monito
Publikováno v:
SPIE Proceedings.
AcoustoNphotonic imaging (API) , combines the technique of diffusiveNphotonNdensityN wave (DPDW) imaging with ultrasound modulation of light in a new mode of medical imaging which promises improved resolution, accuracy, and penetration. Analytical re
Publikováno v:
SPIE Proceedings.
For patients with ischemic stroke there is benefit to early treatment (within 3 hours) with recombinant tissue plasminogen activator, rt-PA, an FDA approved thrombolytic drug. The use of rt-PA within the first 3 hours of an ischemic stroke is based u
Autor:
David A. Boas, Hakan Ay, A. G. Sorenson, Andrew M. Siegel, Thomas J. Gaudette, Walter J. Koroshetz, Lai Wang
Publikováno v:
Biomedical Optics.
For patients with ischemic stroke there is benefit to early treatment (within 3 hours) with recombinant tissue plasminogen activator, rt-PA, an FDA approved thrombolytic drug.
Publikováno v:
Advances in Optical Imaging and Photon Migration.
We are developing a new technique for imaging in optically diffuse media, by combining photon-migration imaging [Boas, et. aL], with ultrasound modulation [Wang et. al.].
Publikováno v:
Optics Express. 8:263
In order for diffuse optical tomography to realize its potential of obtaining quantitative images of spatially varying optical properties within random media, several potential experimental systematic errors must be overcome. One of these errors is t
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.